loading...| Preferred Name |
balsalazide |
|
| Synonyms |
balsalazine |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C038637 |
|
| altLabel |
balsalazine Colazide 5-(carboxyethylcarbamoyl-4-phenylazo)salicylic acid BX661A Colazal balsalazide disodium BX 661A Benzoic acid, 5-((4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxy-, disodium salt |
|
| cui |
C0052940 C0595398 C2742039 C0939297 C0525844 C0595402 |
|
| HM |
D019804 D010659 |
|
| II |
D003093 D015212 D011355 |
|
| Inverse of RB |
P80AL8J7ZP |
|
| isa | ||
| LT |
TRD |
|
| Mapped to | ||
| MDA |
19830811 |
|
| MeSH Frequency |
85 |
|
| MMR |
20141022 |
|
| notation |
C038637 |
|
| PA |
D000894 D005765 |
|
| PI |
*AMINOSALICYLIC ACIDS (1983-2006) |
|
| prefLabel |
balsalazide |
|
| RR |
82101-18-6 (balsalazide) |
|
| SC |
1 |
|
| Scope Statement |
a mesalamine 5-aminosalicylate prodrug; 99% of ingested drug remains intact through the stomach and is delivered to and activated in the colon; used for inflammatory bowel disease, ulcerative colitis and radiation-induced proctosigmoiditis but avoided in patients with known hypersensitivity reaction to salicylates or mesalamine; structure in first source |
|
| SRC |
Dig Dis Sci 1983;28(7):609 |
|
| TERMUI |
T146208 T761601 T461570 T461571 T146209 T146207 T146206 T622278 |
|
| TH |
US UK FDA SRS (2013) NLM (2001) INN (19XX) NLM (2010) NLM (1983) |
|
| tui |
T109 T121 |